Techsomed has announced a collaboration with Medtronic, combining Techsomed’s BioTraceIO360 software and the Medtronic Emprint microwave ablation system as a solution for image-guided ablation therapy.
In a recent press release, the company outlines that, in minimally invasive therapies such as ablation, effective image guidance is crucial. However, challenges such as limited intra-procedural visibility, non-integrated technologies, and reliance on fragmented imaging systems can hinder physicians’ ability to maintain local control of tumour margins, often leading to the need for repeat interventions.
By using Techsomed’s planning, visualisation, and margin confirmation software in combination with the Emprint ablation system with Thermosphere technology, interventional radiologists will arm themselves with advanced capabilities for real-time visualisation, predictive margin control, dynamic treatment planning, and scalable, spherical ablation zones, allowing them to pursue optimal treatment outcomes.
“In collaboration with Medtronic, we aim to set a new standard for minimally invasive ablation treatment—grounded in data, not assumptions,” said Yossi Abu, chief executive officer and founder of Techsomed.
“By adding our advanced imaging, real-time predictive modelling and seamless workflow integration to the cutting-edge ablation technology offered by Medtronic and their industry-leading in-vivo therapy datasets, we aspire to bring a new level of treatment precision to our customers.”
